30 clinical trials matched your search for Lymphoma. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Lymphoma Study of Drug for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease Ran Reshef, MD
Lymphoma Study of Tazemetostat or Placebo with Lenalidomide plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma Jennifer Amengual, MD
Lymphoma Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant Divaya Bhutani, MD
Lymphoma Study of Venetoclax in Addition to Usual Treatment for Patients with Waldenstrm's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) Divaya Bhutani, MD
Lymphoma Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) Jennifer Amengual, MD
Lymphoma Study of TAK-007 in Patients with Non-Hodgkin Lymphoma Ran Reshef, MD
Lymphoma Study of Pembrolizumab, Ibrutinib and Rituximab in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Lymphoma Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Follicular Lymphoma Ran Reshef, MD
Lymphoma Study of Tazemetostat in Combination with Belinostat in Patients with Relapsed or Refractory Lymphoma Jennifer Amengual, MD
Lymphoma Study of ONO-4685 in Patients with T-Cell Lymphoma Barbara Pro, MD
Lymphoma Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma Ran Reshef, MD
Lymphoma Study of KITE-363 vs. KITE-753 in Patients with B-cell Lymphoma Ran Reshef, MD
Lymphoma Study of Tazemetostat or Zanubrutinib for Patients with Large B-Cell Lymphoma (LBCL) Jennifer Amengual, MD
Lymphoma Study of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma Barbara Pro, MD
Lymphoma Treatment After CAR T-Cell Therapy for Patients with Diffuse Large B-cell Lymphoma (DLBCL) Hua-Jay Cherng, MD
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Luca Szalontay, MD
Cancer Study of Drug in Patients with Advanced Solid Malignancies and Lymphoma June Hou, MD
Cancer Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia Ran Reshef, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Multiple Myeloma Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant Divaya Bhutani, MD
Leukemia Study of Pirtobrutinib (LOXO-305) Alone or in Combination With Chemotherapy in Patients with Chronic Lymphocytic Leukemia (CLL) Nicole Lamanna, MD
Cancer ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma Ran Reshef, MD
Leukemia Study of Polatuzumab Vedotin in Combination with Chemotherapy in Subjectswith Richter's Transformation Andrew Lipsky, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Brian Henick, MD
Brain Cancer Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Brain Tumors Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Cancer Study of BGB-16673 in Patients with Leukemia or Lymphoma Nicole Lamanna, MD
Cancer Study of NDI-101150 Alone or in Combination with Pembrolizumab in Patients with Solid Tumors Ryan Moy, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Hua-Jay Cherng, MD
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE